Characterization of the human RB1 promoter and of elements involved in transcriptional regulation.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 8049153)

Published in Cell Growth Differ on May 01, 1994

Authors

R M Gill1, P A Hamel, J Zhe, E Zacksenhaus, B L Gallie, R A Phillips

Author Affiliations

1: Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Ontario, Canada.

Articles citing this

Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet (2002) 2.29

Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev (1998) 1.99

Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet (1996) 1.49

Regulated expression of focal adhesion kinase-related nonkinase, the autonomously expressed C-terminal domain of focal adhesion kinase. Mol Cell Biol (1999) 1.42

Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem (2008) 1.36

Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol (1999) 1.28

Regulation of RB transcription in vivo by RB family members. Mol Cell Biol (2010) 1.18

The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ (2008) 1.16

MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway. Mol Cell Biol (2003) 1.10

Conserved and specific functions of mammalian ssu72. Nucleic Acids Res (2005) 0.90

A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription. Oncogene (2015) 0.88

Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle. J Cell Biol (2000) 0.88

Visualizing dynamic E2F-mediated repression in vivo. Mol Cell Biol (2006) 0.86

Reverse genetic system for the analysis of parvovirus telomeres reveals interactions between transcription factor binding sites in the hairpin stem. J Virol (2003) 0.85

The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation. Mol Cell Biol (2002) 0.82

Exploring the contribution of distal P4 promoter elements to the oncoselectivity of Minute Virus of Mice. Virology (2006) 0.79

A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice. Mol Cancer (2014) 0.79

Constitutive RB1 mutation in a child conceived by in vitro fertilization: implications for genetic counseling. BMC Med Genet (2009) 0.77

Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastoma. Fam Cancer (2008) 0.76

CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer. Bladder Cancer (2017) 0.75

Articles by these authors

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57

Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73

Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell (1985) 6.88

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell (1986) 4.68

Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol (1985) 4.61

The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44

The scid mutation in mice causes a general defect in DNA repair. Nature (1990) 3.85

Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol (1985) 3.69

Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57

Migration and stopover in a small pelagic seabird, the Manx shearwater Puffinus puffinus: insights from machine learning. Proc Biol Sci (2009) 3.03

Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells. J Immunol (1972) 2.83

Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78

The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell (1988) 2.71

Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol (1984) 2.56

Oral maintenance therapy for cholera in adults. Lancet (1968) 2.53

pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev (1996) 2.47

Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A (1985) 2.44

B-lymphocyte subpopulations in the mouse. Organ distribution and ontogeny of immunoglobulin-synthesizing and of mitogen-sensitive cells. Transplant Rev (1975) 2.25

Genetic origin of mutations predisposing to retinoblastoma. Science (1985) 2.22

Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. Nature (1983) 2.20

Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol (1995) 2.13

Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res (1966) 2.09

Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Bull World Health Organ (1969) 2.00

Identification of germline and somatic mutations affecting the retinoblastoma gene. Science (1988) 2.00

Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol (1989) 2.00

Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89

Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87

Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer. Proc Natl Acad Sci U S A (1987) 1.86

Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet (2000) 1.86

Isolation of scid pre-B cells that rearrange kappa light chain genes: formation of normal signal and abnormal coding joins. EMBO J (1989) 1.86

Exploratory analysis of the safety climate and safety behavior relationship. J Safety Res (2004) 1.74

Water and sodium absorption in the human intestine. J Physiol (1968) 1.72

Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature (1983) 1.71

A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69

Preferential germline mutation of the paternal allele in retinoblastoma. Nature (1989) 1.69

A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science (1989) 1.60

Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst (1996) 1.57

Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res (1996) 1.57

Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57

Constraints of interest: lessons at the Hospital for Sick Children. CMAJ (1998) 1.54

Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet (1998) 1.54

Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene (1995) 1.53

Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer (1982) 1.52

Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet (1996) 1.49

Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49

Homogeneity of antibody-producing cells as analysed by their buoyant density in gradients of Ficoll. Immunology (1970) 1.45

Using the rat as a cholera "model". Nature (1968) 1.45

Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer. Nature (1986) 1.44

The retinoblastoma protein and cell cycle regulation. Trends Genet (1992) 1.42

The genetics of retinoblastoma. Relevance to the patient. Pediatr Clin North Am (1991) 1.42

Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol (1999) 1.42

In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41

Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit Rev Biochem Mol Biol (1996) 1.37

The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol (1985) 1.36

Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells. Immunology (1971) 1.35

Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene (1992) 1.35

The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene (1997) 1.34

Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera. Bull World Health Organ (1969) 1.33

Cholera in the perspective of 1966. Ann Intern Med (1966) 1.33

Ontogeny of murine B lymphocytes: development of Ig synthesis and of reactivities to mitogens and to anti-Ig-antibodies. Cold Spring Harb Symp Quant Biol (1977) 1.31

Acetate in the correction of acidosis secondary to diarrhoea. Lancet (1969) 1.31

A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet (1985) 1.31

Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients. J Am Coll Cardiol (1987) 1.30

Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol (1999) 1.28

A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol (1993) 1.27

Intestinal transmural electric potential and its response to glucose in acute and convalescent cholera. Gastroenterology (1969) 1.27

Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25

Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J (1993) 1.24

Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors. Mol Cell Biol (1988) 1.22

Expression of notch receptors, notch ligands, and fringe genes in hematopoiesis. Exp Hematol (2000) 1.22

Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21

Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors. J Immunol (1973) 1.20

An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med (1986) 1.19

Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nat Genet (1997) 1.19

Growth of human tumors in immune-deficient scid mice and nude mice. Curr Top Microbiol Immunol (1989) 1.18

Mutations of the p53 gene do not occur in testis cancer. Cancer Res (1993) 1.17